DR. WILLIAM RAFAEL ROBERTS, O.D.
Optometry at 64 St, Gainesville, FL

License number
Florida OPC5191
Category
Optometry
Type
Optometrist
Address
Address 2
5533 SW 64Th St, Gainesville, FL 32608
8 Birch Ave, Shalimar, FL 32579
Phone
(352) 271-5967
(850) 218-6527

Personal information

See more information about WILLIAM RAFAEL ROBERTS at radaris.com
Name
Address
Phone
William Roberts, age 41
5219 Magnolia Oaks Ln, Jacksonville, FL 32210
(904) 771-2892
William Roberts, age 60
5212 Working Horse Ln, Baker, FL 32531
(850) 537-9689
William Roberts, age 75
520 Shadow Glenn Pl, Winter Springs, FL 32708
William Roberts
508 Canterbury Ln, Kissimmee, FL 34741
(407) 908-6227
William Roberts
5073 99Th St N, St Petersburg, FL 33708

Professional information

See more information about WILLIAM RAFAEL ROBERTS at trustoria.com
William Roberts Photo 1
William Roberts - Gainesville, FL

William Roberts - Gainesville, FL

Work:
Sears
Loss Prevention Manager
Bankers Life - Gainesville, FL
Field Training Representative / Agent
Target - Gainesville, FL
Executive Team Leader of Assets Protection
Food Lion, LLC - Salisbury, NC
Regional Loss Prevention Manager
Education:
Huron College - Huron, SD
Bachelor of Science in Science Criminal Justice / HPER
Marion Military Institute - Marion, AL
General Studies
Skills:
Reid Interview and Interrogation Technique 1991, Reid Interview and Interrogation Technique Advanced 1997, LSI Scan 1995, Wicklander - Zulawski 2011


William Roberts Photo 2
Bioavailable Prodrugs Of Androgenic Steroids And Related Method

Bioavailable Prodrugs Of Androgenic Steroids And Related Method

US Patent:
6740646, May 25, 2004
Filed:
Jan 16, 2002
Appl. No.:
10/053345
Inventors:
William J. Roberts - Gainesville FL
Assignee:
Biotest Laboratories, LLC - Colorado Springs CO
International Classification:
A61K 31568
US Classification:
514178, 514182, 552633
Abstract:
A compound is provided for increasing the concentration of a parent androgen in a subject in vivo. The parent androgen has a skeletal structure including a 1 position and a 17 position, a 17-hydroxy group comprising a 17-hydroxy oxygen appended to the 17 position, and a 17-hydroxy hydrogen appended to the 17-hydroxy oxygen. The compound includes a substrate having the skeletal structure of the parent androgen. It includes a 1 position and a 17 position corresponding to the 1 and 17 positions respectively of the parent androgen. The substrate has a carbon—carbon double bond at the 1 position. The compound also has a promoiety appended to the 17-hydroxy oxygen of the substrate as a substitute for the 17-hydroxy hydrogen of the parent androgen. The promoiety includes, and preferably consists of, an alkylcarbonate ester. A related method also is provided.


William Roberts Photo 3
5-Alkyl-7-Alkylcarbonate-Isoflavone Ester And Related Method

5-Alkyl-7-Alkylcarbonate-Isoflavone Ester And Related Method

US Patent:
6818668, Nov 16, 2004
Filed:
Apr 12, 2002
Appl. No.:
10/123068
Inventors:
William J. Roberts - Gainesville FL
Assignee:
Biotest Laboratories, LLC - Colorado Springs CO
International Classification:
A61K 3135
US Classification:
514456, 514457, 549402, 549403
Abstract:
A compound is provided for increasing the concentration of a parent isoflavone in a subject in vivo. The parent isoflavone has a skeletal structure including a 5 position and a 7 position, a 5 alkyl group, and a 7-hydroxy group with a 7-hydroxy oxygen appended to the 7 position and a 7-hydroxy hydrogen appended to the 7-hydroxy oxygen. The compound includes a substrate having the skeletal structure of the parent isoflavone, with a 5 position and a 7 position corresponding to the 5 and 7 positions respectively of the parent isoflavone. An alkyl group is appended to the 5 position. A promoiety is appended to the 7-hydroxy oxygen of the substrate as a substitute for the 7-hydroxy hydrogen of the parent isoflavone, the promoiety and the 7-hydroxy oxygen establishing an alkylcarbonate ester. A related method also is provided.


William Roberts Photo 4
Composition And Method For Increasing In Vivo Androgen Concentration

Composition And Method For Increasing In Vivo Androgen Concentration

US Patent:
2003013, Jul 17, 2003
Filed:
Oct 3, 2002
Appl. No.:
10/265218
Inventors:
William Roberts - Gainesville FL, US
International Classification:
A61K031/573
US Classification:
514/170000
Abstract:
A composition is provided including a first prohormone for increasing the concentration of a Class I parent androgen in a subject in vivo, and a second prohormone for increasing the concentration of a Class II parent androgen in the subject in vivo. The first prohormone includes a first carbon-carbon double bond at the 1 position, and a first 17-hydroxy oxygen appended to the 17 position. The first prohormone further includes a first 17-position promoiety is appended to the first 17-hydroxy oxygen as a substitute for the 17-hydroxy hydrogen of the Class I parent androgen. The second prohormone includes a second carbon-carbon double bond at the 4 position and a second 17-hydroxy oxygen appended to the 17 position. The second prohormone also includes a second 17-position promoiety appended to the second 17-hydroxy oxygen as a substitute for the 17-hydroxy hydrogen of the Class II parent androgen.


William Roberts Photo 5
Bioavailable Prodrugs Of Androgenic Steroids And Related Method

Bioavailable Prodrugs Of Androgenic Steroids And Related Method

US Patent:
2003013, Jul 17, 2003
Filed:
Jan 16, 2002
Appl. No.:
10/053505
Inventors:
William Roberts - Gainesville FL, US
International Classification:
A61K031/57, C07J001/00
US Classification:
514/178000, 552/639000
Abstract:
A compound is provided for increasing the concentration of a parent androgen in a subject in vivo. The parent androgen has a skeletal structure including a 4 position and a 17 position. It has a 17-hydroxy group that includes a 17-hydroxy oxygen appended to the 17 position and a 17-hydroxy hydrogen appended to the 17-hydroxy oxygen. The compound includes a substrate having the skeletal structure of the parent androgen, wherein the substrate includes a 4 position and a 17 position corresponding to the 4 and 17 positions respectively of the parent androgen. The substrate according to one aspect of the invention includes a carbon-carbon double bond at the 4 position. The skeletal structure of the parent androgen embodied in the substrate being selected from the group consisting of androst-4-ene-3,17-diol, androst-4-ene-3,17-diol, and mixtures thereof, or estr-4-ene-3,17-diol, estr-4-ene-3,17-diol, and mixtures thereof, or combinations of these. A promoiety is appended to the 17-hydroxy oxygen of the substrate as a substitute for the hydroxy hydrogen of the parent androgen. The promoiety constitutes or includes an alkylcarbonate ester. Related methods are included as well.


William Roberts Photo 6
Bioavailable Prodrugs Of Androgenic Steroids And Related Method

Bioavailable Prodrugs Of Androgenic Steroids And Related Method

US Patent:
2005011, May 26, 2005
Filed:
May 25, 2004
Appl. No.:
10/854028
Inventors:
William Roberts - Gainesville FL, US
International Classification:
A61K031/56
US Classification:
514182000
Abstract:
A compound is provided for increasing the concentration of a parent androgen in a subject in vivo. The parent androgen has a skeletal structure including a 1 position and a 17 position, a 17β-hydroxy group comprising a 17β-hydroxy oxygen appended to the 17 position, and a 17β-hydroxy hydrogen appended to the 17β-hydroxy oxygen. The compound includes a substrate having the skeletal structure of the parent androgen. It includes a 1 position and a 17 position corresponding to the 1 and 17 positions respectively of the parent androgen. The substrate has a carbon-carbon double bond at the 1 position. The compound also has a promoiety appended to the 17β-hydroxy oxygen of the substrate as a substitute for the 17β-hydroxy hydrogen of the parent androgen. The promoiety includes, and preferably consists of, an alkylcarbonate ester. A related method also is provided.


William Roberts Photo 7
5-Alkyl-7-Alkylcarbonate-Isoflavone Ester And Related Method

5-Alkyl-7-Alkylcarbonate-Isoflavone Ester And Related Method

US Patent:
7625943, Dec 1, 2009
Filed:
Jun 14, 2004
Appl. No.:
10/868164
Inventors:
William J. Roberts - Gainesville FL, US
International Classification:
A61K 31/352
US Classification:
514456
Abstract:
A compound is provided for increasing the concentration of a parent isoflavone in a subject in vivo. The parent isoflavone has a skeletal structure including a 5 position and a 7 position, a 5 alkyl group, and a 7-hydroxy group with a 7-hydroxy oxygen appended to the 7 position and a 7-hydroxy hydrogen appended to the 7-hydroxy oxygen. The compound includes a substrate having the skeletal structure of the parent isoflavone, with a 5 position and a 7 position corresponding to the 5 and 7 positions respectively of the parent isoflavone. An alkyl group is appended to the 5 position. A promoiety is appended to the 7-hydroxy oxygen of the substrate as a substitute for the 7-hydroxy hydrogen of the parent isoflavone the promoiety and the 7-hydroxy oxygen establishing an alkylcarbonate ester. A related method also is provided.


William Roberts Photo 8
Bioavailable Prodrugs Of Androgenic Steroids And Related Method

Bioavailable Prodrugs Of Androgenic Steroids And Related Method

US Patent:
2002018, Dec 5, 2002
Filed:
Jun 1, 2001
Appl. No.:
09/872705
Inventors:
William Roberts - Gainesville FL, US
International Classification:
C07J003/00, A61K031/56, C07J001/00
US Classification:
552/611000, 552/638000, 514/178000
Abstract:
A compound for supplementing the concentration of a parent androgen in a subject in vivo, wherein the parent androgen has a skeletal structure including a 17 position and the parent androgen further has a 17-hydroxy group comprising a 17-hydroxy hydrogen appended to the 17 position. The compound comprises a substrate having the skeletal structure of the parent androgen including a 17 position corresponding to the 17 position of the parent androgen, and a promoiety comprising an alkoxymethyl ether appended to the 17 position of the substrate as a substitute for the 17-hydroxy hydrogen. Related compounds and methods also are disclosed.